Melissa Epperly - 20 Jul 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: Director
Signature: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly
Issuer symbol: ROIV
Transactions as of: 20 Jul 2022
Transactions value $: $0
Form type: 4
Filing time: 25 Jul 2022, 06:06:01 UTC
Previous filing: 11 Jul 2022
Next filing: 03 Oct 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ROIV	Stock Option (Right to Buy)	Award	$0	+186,916		$0	186,916	20 Jul 2022	Common Shares	186,916	$4.46	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of stock options to purchase Common Shares with a vesting commencement date of June 29, 2022. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date., subject to the reporting person's continuous service through the applicable vesting date.

Content

Award of stock options to purchase Common Shares with a vesting commencement date of June 29, 2022. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date., subject to the reporting person's continuous service through the applicable vesting date.